Blue Sail Medical Co Ltd (002382) — Strategic Asset Allocation Index
Blue Sail Medical Co Ltd (002382) has a Strategic Asset Allocation Index of 54.6% as of September 2023. Strategic assets (PP&E of CN¥5.43 Billion plus long-term investments of CN¥-) total CN¥5.43 Billion, measured against net assets of CN¥9.93 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Blue Sail Medical Co Ltd Strategic Asset Allocation Index (2007–2022)
This chart shows how Blue Sail Medical Co Ltd's Strategic Asset Allocation Index has evolved across 16 annual periods from 2007 to 2022. As of September 2023, the index stands at 54.6%, representing strategic assets of CN¥5.43 Billion against net assets of CN¥9.93 Billion CNY. Explore Blue Sail Medical Co Ltd operating cash flow efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Blue Sail Medical Co Ltd (2007–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Blue Sail Medical Co Ltd from 2007 to 2022, covering 16 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 002382 company net worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 52.0% | CN¥5.49 Billion | CN¥5.49 Billion | CN¥- | CN¥10.55 Billion | ▲ +0.0 pp |
| 2021 | 52.0% | CN¥5.48 Billion | CN¥5.48 Billion | CN¥- | CN¥10.54 Billion | ▲ +26.8 pp |
| 2020 | 25.1% | CN¥2.47 Billion | CN¥2.47 Billion | CN¥- | CN¥9.82 Billion | ▲ +4.8 pp |
| 2019 | 20.4% | CN¥1.73 Billion | CN¥1.73 Billion | CN¥- | CN¥8.46 Billion | ▼ -1.1 pp |
| 2018 | 21.5% | CN¥1.67 Billion | CN¥1.67 Billion | CN¥- | CN¥7.80 Billion | ▼ -33.4 pp |
| 2017 | 54.8% | CN¥783.17 Million | CN¥783.17 Million | CN¥- | CN¥1.43 Billion | ▲ +12.5 pp |
| 2016 | 42.3% | CN¥550.43 Million | CN¥550.43 Million | CN¥- | CN¥1.30 Billion | ▼ -2.7 pp |
| 2015 | 45.0% | CN¥532.76 Million | CN¥532.76 Million | CN¥- | CN¥1.18 Billion | ▼ -7.5 pp |
| 2014 | 52.5% | CN¥548.77 Million | CN¥548.77 Million | CN¥- | CN¥1.05 Billion | ▼ -62.4 pp |
| 2013 | 114.9% | CN¥1.13 Billion | CN¥1.13 Billion | CN¥- | CN¥984.34 Million | ▲ +43.9 pp |
| 2012 | 71.0% | CN¥682.95 Million | CN¥682.95 Million | CN¥- | CN¥961.83 Million | ▲ +18.8 pp |
| 2011 | 52.2% | CN¥478.43 Million | CN¥478.43 Million | CN¥- | CN¥916.68 Million | ▲ +24.2 pp |
| 2010 | 28.0% | CN¥253.22 Million | CN¥253.22 Million | CN¥- | CN¥903.72 Million | ▼ -31.4 pp |
| 2009 | 59.4% | CN¥120.78 Million | CN¥120.78 Million | CN¥- | CN¥203.26 Million | ▼ -12.6 pp |
| 2008 | 72.0% | CN¥114.08 Million | CN¥114.08 Million | CN¥- | CN¥158.41 Million | ▼ -2.7 pp |
| 2007 | 74.7% | CN¥72.54 Million | CN¥72.54 Million | CN¥- | CN¥97.05 Million | — |